Uniqure NV (QURE) Reaches $8.39 After 5.00% Down Move, 3 Analysts Are Bullish Curtiss-Wright Corp. (CW) Last Week

July 25, 2017 - By Adrian Mccoy

Among 5 analysts covering Curtiss-Wright (NYSE:CW), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. Curtiss-Wright had 10 analyst reports since July 31, 2015 according to SRatingsIntel. The company was upgraded on Monday, June 5 by SunTrust. The stock has “Buy” rating by Deutsche Bank on Friday, July 31. The company was maintained on Monday, June 13 by Deutsche Bank. The firm has “Hold” rating given on Thursday, January 19 by Suntrust Robinson. On Monday, December 5 the stock rating was maintained by Deutsche Bank with “Buy”. The company was downgraded on Friday, November 11 by Bank of America. Suntrust Robinson upgraded Curtiss-Wright Corp. (NYSE:CW) on Monday, June 5 to “Buy” rating. The firm earned “Neutral” rating on Friday, November 11 by CL King. CL King initiated the stock with “Buy” rating in Friday, October 16 report. The stock of Curtiss-Wright Corp. (NYSE:CW) has “Hold” rating given on Thursday, January 19 by SunTrust. See Curtiss-Wright Corp. (NYSE:CW) latest ratings:

05/06/2017 Broker: Suntrust Robinson Old Rating: Hold New Rating: Buy Upgrade
05/06/2017 Broker: SunTrust Rating: Buy New Target: $112.0000 Upgrade

The stock of Uniqure NV (NASDAQ:QURE) is a huge mover today! About 123,590 shares traded. Uniqure NV (NASDAQ:QURE) has declined 52.65% since July 25, 2016 and is downtrending. It has underperformed by 69.35% the S&P500.The move comes after 8 months negative chart setup for the $234.10M company. It was reported on Jul, 25 by Barchart.com. We have $7.97 PT which if reached, will make NASDAQ:QURE worth $11.71 million less.

Uniqure NV is a gene therapy company based in the Netherlands. The company has market cap of $234.10 million. The Firm is engaged in the discovery, development and commercialization of single treatments with curative results for patients suffering from genetic and other severe diseases. It currently has negative earnings. The Firm advances a focused pipeline of gene therapies that are developed both internally and through partnerships.

Analysts await Uniqure NV (NASDAQ:QURE) to report earnings on August, 24. They expect $-0.86 EPS, up 12.24% or $0.12 from last year’s $-0.98 per share. After $-0.80 actual EPS reported by Uniqure NV for the previous quarter, Wall Street now forecasts 7.50% negative EPS growth.

Among 12 analysts covering uniQure N.V. (NASDAQ:QURE), 9 have Buy rating, 0 Sell and 3 Hold. Therefore 75% are positive. uniQure N.V. had 24 analyst reports since August 7, 2015 according to SRatingsIntel. The company was maintained on Wednesday, June 15 by WallachBeth Capital. WallachBeth Capital initiated it with “Buy” rating and $35 target in Friday, August 7 report. Roth Capital maintained Uniqure NV (NASDAQ:QURE) on Monday, September 21 with “Buy” rating. Chardan Capital Markets maintained Uniqure NV (NASDAQ:QURE) on Tuesday, July 18 with “Buy” rating. The firm earned “Outperform” rating on Monday, September 21 by Oppenheimer. The firm has “Buy” rating given on Friday, August 28 by WallachBeth Capital. TH Capital reinitiated the shares of QURE in report on Monday, November 30 with “Buy” rating. The stock of Uniqure NV (NASDAQ:QURE) earned “Buy” rating by Chardan Capital Markets on Thursday, October 1. The company was maintained on Friday, August 28 by Piper Jaffray. WallachBeth Capital maintained the shares of QURE in report on Tuesday, December 1 with “Buy” rating.

Curtiss-Wright Corporation is a manufacturing and service firm that designs, makes, and overhauls precision components and provides engineered services and products to the aerospace, defense, power generation and general industrial markets. The company has market cap of $4.35 billion. The Firm operates through three divisions: Commercial/Industrial, Defense and Power. It has a 23.22 P/E ratio. The Commercial/Industrial segment’s products include electronic throttle control devices and transmission shifters, electro-mechanical actuation control components, valves, and surface technology services.

Investors sentiment increased to 1.16 in 2016 Q4. Its up 0.10, from 1.06 in 2016Q3. It increased, as 19 investors sold Curtiss-Wright Corp. shares while 82 reduced holdings. 39 funds opened positions while 78 raised stakes. 32.66 million shares or 1.83% less from 33.27 million shares in 2016Q3 were reported. Raymond James And Assocs accumulated 63,728 shares or 0.02% of the stock. Fmr Ltd Liability Com invested in 0.01% or 408,147 shares. Primecap Mgmt Ca owns 0.12% invested in Curtiss-Wright Corp. (NYSE:CW) for 1.21 million shares. Hsbc Hldgs Plc holds 0% or 10,222 shares. Moreover, New York Life Tru has 0.1% invested in Curtiss-Wright Corp. (NYSE:CW) for 217 shares. Jacobs Levy Equity Management invested in 21,225 shares. Stifel Fincl stated it has 0% of its portfolio in Curtiss-Wright Corp. (NYSE:CW). Verition Fund Lc holds 0.06% or 7,161 shares. Acadian Asset Lc stated it has 0.01% of its portfolio in Curtiss-Wright Corp. (NYSE:CW). State Of Wisconsin Invest Board reported 119,126 shares stake. Cardinal Mgmt accumulated 7,294 shares. Comerica Fincl Bank holds 0.03% in Curtiss-Wright Corp. (NYSE:CW) or 42,286 shares. Old Mutual Global Investors (Uk) reported 0.01% in Curtiss-Wright Corp. (NYSE:CW). New York-based Gabelli & Investment Advisers has invested 0.06% in Curtiss-Wright Corp. (NYSE:CW). South Dakota Inv Council stated it has 0.01% in Curtiss-Wright Corp. (NYSE:CW).

About 43,523 shares traded. Curtiss-Wright Corp. (NYSE:CW) has risen 4.96% since July 25, 2016 and is uptrending. It has underperformed by 11.74% the S&P500.

Since February 8, 2017, it had 0 buys, and 8 selling transactions for $5.97 million activity. Jakubowitz Harry sold $143,197 worth of stock. $890,076 worth of Curtiss-Wright Corp. (NYSE:CW) was sold by Quinly Tom P on Wednesday, February 8. The insider Adams David Charles sold $1.50M. The insider TYNAN GLENN E sold 7,245 shares worth $710,517. Another trade for 2,585 shares valued at $253,511 was made by Ferdenzi Paul J on Wednesday, February 8. On Wednesday, June 7 the insider FULLER S MARCE sold $117,840.